Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. 4 Insider Changes in Ownership
  2. 10-K Report Annual Report
  3. NT 10-K Other NT 10-K
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 424B3 Offering Prospectus
  7. 424B3 Offering Prospectus
  8. 424B3 Offering Prospectus
  9. FWP Offering Free Writing Prospectus
  10. FWP Offering Free Writing Prospectus
  11. 424B3 Offering Prospectus
  12. CERTNAS Other Certification by the Nasdaq Stock Market
  13. EFFECT Other Notice of Effectiveness
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 63 of 64 · 1,274 filings